The DOI matches its Crossref record; 575 of the 575 references it cites were found in a registry or an index.
Molecular distinction between physiological and pathological cardiac hypertrophy: Experimental findings and therapeutic strategies
Open accessAbstract
Cardiac hypertrophy can be defined as an increase in heart mass. Pathological cardiac hypertrophy (heart growth that occurs in settings of disease, e.g. hypertension) is a key risk factor for heart failure. Pathological hypertrophy is associated with increased interstitial fibrosis, cell death and cardiac dysfunction. In contrast, physiological cardiac hypertrophy (heart growth that occurs in response to chronic exercise training, i.e. the 'athlete's heart') is reversible and is characterized by normal cardiac morphology (i.e. no fibrosis or apoptosis) and normal or enhanced cardiac function. Given that there are clear functional, structural, metabolic and molecular differences between pathological and physiological hypertrophy, a key question in cardiovascular medicine is whether mechanisms responsible for enhancing function of the athlete's heart can be exploited to benefit patients with pathological hypertrophy and heart failure. This review summarizes key experimental findings that have contributed to our understanding of pathological and physiological heart growth. In particular, we focus on signaling pathways that play a causal role in the development of pathological and physiological hypertrophy. We discuss molecular mechanisms associated with features of cardiac hypertrophy, including protein synthesis, sarcomeric organization, fibrosis, cell death and energy metabolism and provide a summary of profiling studies that have examined genes, microRNAs and proteins that are differentially expressed in models of pathological and physiological hypertrophy. How gender and sex hormones affect cardiac hypertrophy is also discussed. Finally, we explore how knowledge of molecular mechanisms underlying pathological and physiological hypertrophy may influence therapeutic strategies for the treatment of cardiovascular disease and heart failure.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Items 201–400 of 575
Lower skeletal muscle mass in male transgenic mice with muscle-specific overexpression of myostatin
Reisz-Porszasz, S., Bhasin, S., Artaza, J. N., Shen, R., Sinha-Hikim, I., Hogue, A., Fielder, T. J., & Gonzalez-Cadavid, N. F. (2003) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00107.2003 · Cited by 333
The Fuzzy Logic of Physiological Cardiac Hypertrophy
Dorn, G. W. (2007) · Hypertension · doi:10.1161/hypertensionaha.106.079426 · Cited by 333
Braz, J. C., Bueno, O. F., Liang, Q., Wilkins, B. J., Dai, Y.-S., Parsons, S., Braunwart, J., Glascock, B. J., Klevitsky, R., Kimball, T. F., et al. (2003) · Journal of Clinical Investigation · doi:10.1172/jci17295 · Cited by 332
Hoch, B., Meyer, R., Hetzer, R., Krause, E.-G., & Karczewski, P. (1999) · Circulation Research · doi:10.1161/01.res.84.6.713 · Cited by 328
Cardiac hypertrophy-induced changes in mRNA levels for TGF-beta 1, fibronectin, and collagen
Villarreal, F. J., & DILLMANN, W. H. (1992) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.1992.262.6.h1861 · Cited by 320
Symptom distress and quality of life in patients with advanced congestive heart failure
Blinderman, C. D., Homel, P., Billings, J. A., Portenoy, R. K., & Tennstedt, S. L. (2008) · Journal of Pain and Symptom Management · doi:10.1016/j.jpainsymman.2007.06.007 · Cited by 318
Beneficial effects of long-term beta-blockade in congestive cardiomyopathy.
Swedberg, K., Hjalmarson, A., Waagstein, F., & Wallentin, I. (1980) · Heart · doi:10.1136/hrt.44.2.117 · Cited by 318
Oliverio, M. I., Kim, H.-S., Ito, M., Le, T., Audoly, L., Best, C. F., Hiller, S., Kluckman, K., Maeda, N., Smithies, O., et al. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.26.15496 · Cited by 316
Crosstalk Between Autophagy and Apoptosis in Heart Disease
Nishida, K., Yamaguchi, O., & Otsu, K. (2008) · Circulation Research · doi:10.1161/circresaha.108.175448 · Cited by 316
Mitogen-Activated Protein Kinases in Heart Development and Diseases
Wang, Y. (2007) · Circulation · doi:10.1161/circulationaha.106.679589 · Cited by 315
Hunter, J. J., Tanaka, N., Rockman, H. A., Ross, J., & Chien, K. R. (1995) · Journal of Biological Chemistry · doi:10.1074/jbc.270.39.23173 · Cited by 312
Development and proliferative capacity of cardiac muscle cells.
Zak, R. (1974) · PubMed · Cited by 312
Mechanism of Thyroid Hormone Action
Harvey, C. B., & Williams, G. R. (2002) · Thyroid · doi:10.1089/105072502760143791 · Cited by 306
Ren, J., Samson, W. K., & Sowers, J. R. (1999) · Journal of Molecular and Cellular Cardiology · doi:10.1006/jmcc.1999.1036 · Cited by 304
MicroRNA Regulation of Cardiovascular Development
Cordes, K. R., & Srivastava, D. (2009) · Circulation Research · doi:10.1161/circresaha.108.192872 · Cited by 304
Jennings, G., Nelson, L., Nestel, P., Esler, M., Korner, P., Burton, D., & Bazelmans, J. (1986) · Circulation · doi:10.1161/01.cir.73.1.30 · Cited by 301
17β-Estradiol Attenuates the Development of Pressure-Overload Hypertrophy
van Eickels, M., Grohé, C., Cleutjens, J. P. M., Janssen, B. J., Wellens, H. J. J., & Doevendans, P. A. (2001) · Circulation · doi:10.1161/hc3601.095577 · Cited by 300
Rosenkranz, S., Flesch, M., Amann, K., Haeuseler, C., Kilter, H., Seeland, U., Schlüter, K.-D., & Böhm, M. (2002) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.00578.2001 · Cited by 300
McMullen, J. R., Amirahmadi, F., Woodcock, E. A., Schinke-Braun, M., Bouwman, R. D., Hewitt, K. A., Mollica, J. P., Zhang, L., Zhang, Y., Shioi, T., et al. (2007) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0606663104 · Cited by 299
Self-citationSex differences in cardiac adaptation to isolated systolic hypertension
Krumholz, H. M., Larson, M., & Levy, D. (1993) · The American Journal of Cardiology · doi:10.1016/0002-9149(93)90678-6 · Cited by 298
Hormone Therapy: Physiological Complexity Belies Therapeutic Simplicity
Turgeon, J. L., McDonnell, D. P., Martin, K. A., & Wise, P. M. (2004) · Science · doi:10.1126/science.1096725 · Cited by 297
Brancaccio, M., Fratta, L., Notte, A., Hirsch, E., Poulet, R., Guazzone, S., De Acetis, M., Vecchione, C., Marino, G., Altruda, F., et al. (2003) · Nature Medicine · doi:10.1038/nm805 · Cited by 296
Zannad, F., Briancon, S., Juilliere, Y., Mertes, P.-M., Villemot, J.-P., Alla, F., & Virion, J.-M. (1999) · Journal of the American College of Cardiology · doi:10.1016/s0735-1097(98)00634-2 · Cited by 295
Nelson, L., Esler, M., Jennings, G., & Korner, P. (1986) · The Lancet · doi:10.1016/s0140-6736(86)90354-5 · Cited by 295
Targeted inhibition of calcineurin prevents agonist-induced cardiomyocyte hypertrophy
Taigen, T., De Windt, L. J., Lim, H. W., & Molkentin, J. D. (2000) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.97.3.1196 · Cited by 294
Myocyte-enriched calcineurin-interacting protein, MCIP1, inhibits cardiac hypertrophy in vivo
Rothermel, B. A., McKinsey, T. A., Vega, R. B., Nicol, R. L., Mammen, P., Yang, J., Antos, C. L., Shelton, J. M., Bassel-Duby, R., Olson, E. N., et al. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.041614798 · Cited by 294
Kalra, P. R., Moon, J. C. C., & Coats, A. J. S. (2002) · International Journal of Cardiology · doi:10.1016/s0167-5273(02)00182-1 · Cited by 293
Reiss, K., Cheng, W., Ferber, A., Kajstura, J., Li, P., Li, B., Olivetti, G., Homcy, C. J., Baserga, R., & Anversa, P. (1996) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.93.16.8630 · Cited by 292
Catecholamines, Cardiac β-Adrenergic Receptors, and Heart Failure
Lefkowitz, R. J., Rockman, H. A., & Koch, W. J. (2000) · Circulation · doi:10.1161/01.cir.101.14.1634 · Cited by 291 · cited 1×
“…system has an adverse effect on the heart that contributes to the pathogenesis of heart failure, preservation of normal β-AR-G protein coupling is critical during times of need, such as periods of stress and during exercise (Christensen & Galbo, 1983; Lefkowitz et al., 2000; Rockman et al., 2002).”
BackgroundHarwood, A. J. (2001) · Cell · doi:10.1016/s0092-8674(01)00412-3 · Cited by 291
Calcineurin Signaling and Muscle Remodeling
Olson, E. N., & Williams, R. S. (2000) · Cell · doi:10.1016/s0092-8674(00)80880-6 · Cited by 290
Yamazaki, T., Tobe, K., Hoh, E., Maemura, K., Kaida, T., Komuro, I., Tamemoto, H., Kadowaki, T., Nagai, R., & Yazaki, Y. (1993) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(19)50309-x · Cited by 290
Genetic Dissection of Cardiac Growth Control Pathways
MacLellan, W. R., & Schneider, M. D. (2000) · Annual Review of Physiology · doi:10.1146/annurev.physiol.62.1.289 · Cited by 289
Oestrogen protects FKBP12.6 null mice from cardiac hypertrophy
Xin, H.-B., Senbonmatsu, T., Cheng, D.-S., Wang, Y.-X., Copello, J. A., Ji, G.-J., Collier, M. L., Deng, K.-Y., Jeyakumar, L. H., Magnuson, M. A., et al. (2002) · Nature · doi:10.1038/416334a · Cited by 286
Therapeutic implications of the gender-specific aspects of cardiovascular disease
Regitz-Zagrosek, V. (2006) · Nature Reviews Drug Discovery · doi:10.1038/nrd2032 · Cited by 284
The relationship between myocardial extracellular matrix remodeling and ventricular function☆
Brower, G. L., Gardner, J. D., Forman, M. F., Murray, D. B., Voloshenyuk, T., Levick, S. P., & Janicki, J. S. (2006) · European Journal of Cardio-Thoracic Surgery · doi:10.1016/j.ejcts.2006.07.006 · Cited by 284
Douglas, P. S., Katz, S. E., Weinberg, E. O., Chen, M. H., Bishop, S. P., & Lorell, B. H. (1998) · Journal of the American College of Cardiology · doi:10.1016/s0735-1097(98)00347-7 · Cited by 282
Activated MEK5 induces serial assembly of sarcomeres and eccentric cardiac hypertrophy
Nicol, R. L. (2001) · The EMBO Journal · doi:10.1093/emboj/20.11.2757 · Cited by 281
Pellegrini, S., & Dusanter‐Fourt, I. (1997) · European Journal of Biochemistry · doi:10.1111/j.1432-1033.1997.00615.x · Cited by 281
Shai, S.-Y., Harpf, A. E., Babbitt, C. J., Jordan, M. C., Fishbein, M. C., Chen, J., Omura, M., Leil, T. A., Becker, K. D., Jiang, M., et al. (2002) · Circulation Research · doi:10.1161/hh0402.105790 · Cited by 281
Vasan, R. S., Sullivan, L. M., D'Agostino, R. B., Roubenoff, R., Harris, T., Sawyer, D. B., Levy, D., & Wilson, P. W. F. (2003) · Annals of Internal Medicine · doi:10.7326/0003-4819-139-8-200310210-00007 · Cited by 279
Evidence of oxidative stress in chronic heart failure in humans
McMURRAY, J., CHOPRA, M., ABDULLAH, I., SMITH, W. E., & DARGIE, H. J. (1993) · European Heart Journal · doi:10.1093/eurheartj/14.11.1493 · Cited by 278
Yamamoto, S., Yang, G., Zablocki, D., Liu, J., Hong, C., Kim, S.-J., Soler, S., Odashima, M., Thaisz, J., Yehia, G., et al. (2003) · Journal of Clinical Investigation · doi:10.1172/jci17459 · Cited by 278
Phenotyping Hypertrophy: Eschew Obfuscation
Dorn, G. W., Robbins, J., & Sugden, P. H. (2003) · Circulation Research · doi:10.1161/01.res.0000077012.11088.bc · Cited by 277
Packer, M., McMurray, J., Massie, B. M., Caspi, A., Charlon, V., Cohen-Solal, A., Kiowski, W., Kostuk, W., Krum, H., Levine, B., et al. (2005) · Journal of Cardiac Failure · doi:10.1016/j.cardfail.2004.05.006 · Cited by 275
Wikman-Coffelt, J., Parmley, W. W., & Mason, D. T. (1979) · Circulation Research · doi:10.1161/01.res.45.6.697 · Cited by 274
Cytoskeletal Role in the Contractile Dysfunction of Hypertrophied Myocardium
Tsutsui, H., Ishihara, K., & Cooper, G. (1993) · Science · doi:10.1126/science.8097594 · Cited by 274
Kunisada, K., Negoro, S., Tone, E., Funamoto, M., Osugi, T., Yamada, S., Okabe, M., Kishimoto, T., & Yamauchi-Takihara, K. (2000) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.97.1.315 · Cited by 273
Survival pathways in hypertrophy and heart failure: The gp130-STAT3 axis
Fischer, P., & Hilfiker-Kleiner, D. (2007) · Basic Research in Cardiology · doi:10.1007/s00395-007-0674-z · Cited by 272
Heart, stroke and vascular diseases, Australian facts
Reid, C. (2001) · Heart, Lung and Circulation · doi:10.1046/j.1444-2892.2001.00075.x · Cited by 271
MicroRNA-1 Regulates Cardiomyocyte Apoptosis by Targeting Bcl-2
Tang, Y., Zheng, J., Sun, Y., Wu, Z., Liu, Z., & Huang, G. (2009) · International Heart Journal · doi:10.1536/ihj.50.377 · Cited by 270
Perrino, C. (2006) · Journal of Clinical Investigation · doi:10.1172/jci25397 · Cited by 268
The Emerging Role of MicroRNAs in Cardiac Remodeling and Heart Failure
Divakaran, V., & Mann, D. L. (2008) · Circulation Research · doi:10.1161/circresaha.108.183087 · Cited by 267
Myocardial-Directed Overexpression of the Human β1-Adrenergic Receptor in Transgenic Mice
Bisognano, J. D., Weinberger, H. D., Bohlmeyer, T. J., Pende, A., Raynolds, M. V., Sastravaha, A., Roden, R., Asano, K., Blaxall, B. C., Wu, S. C., et al. (2000) · Journal of Molecular and Cellular Cardiology · doi:10.1006/jmcc.2000.1123 · Cited by 264
Growth of the heart in health and disease
Sheridan, D. J. (1985) · International Journal of Cardiology · doi:10.1016/0167-5273(85)90365-1 · Cited by 263
Crystal Structure of p38 Mitogen-activated Protein Kinase
Wilson, K. P., Fitzgibbon, M. J., Caron, P. R., Griffith, J. P., Chen, W., McCaffrey, P. G., Chambers, S. P., & Su, M. S.-S. (1996) · Journal of Biological Chemistry · doi:10.1074/jbc.271.44.27696 · Cited by 262
Wilkins, B. J., De Windt, L. J., Bueno, O. F., Braz, J. C., Glascock, B. J., Kimball, T. F., & Molkentin, J. D. (2002) · Molecular and Cellular Biology · doi:10.1128/mcb.22.21.7603-7613.2002 · Cited by 262
MATSUI, T., & ROSENZWEIG, A. (2005) · Journal of Molecular and Cellular Cardiology · doi:10.1016/j.yjmcc.2004.11.005 · Cited by 261
Cell growth control by G protein-coupled receptors: from signal transduction to signal integration
Gutkind, J. S. (1998) · Oncogene · doi:10.1038/sj.onc.1202186 · Cited by 261
Masaki, H., Kurihara, T., Yamaki, A., Inomata, N., Nozawa, Y., Mori, Y., Murasawa, S., Kizima, K., Maruyama, K., Horiuchi, M., et al. (1998) · Journal of Clinical Investigation · doi:10.1172/jci1885 · Cited by 260
Srinivasan, M., Edman, C. F., & Schulman, H. (1994) · The Journal of cell biology · doi:10.1083/jcb.126.4.839 · Cited by 260
Hoshijima, M. (2006) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.00816.2005 · Cited by 260
Morisco, C., Zebrowski, D., Condorelli, G., Tsichlis, P., Vatner, S. F., & Sadoshima, J. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.275.19.14466 · Cited by 258
Mende, U., Kagen, A., Cohen, A., Aramburu, J., Schoen, F. J., & Neer, E. J. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.23.13893 · Cited by 258
Cellular Action of Thyroid Hormone on the Heart
Dillmann, W. H. (2002) · Thyroid · doi:10.1089/105072502760143809 · Cited by 252
The MEF2D transcription factor mediates stress-dependent cardiac remodeling in mice
Kim, Y., Phan, D., van Rooij, E., Wang, D.-Z., McAnally, J., Qi, X., Richardson, J. A., Hill, J. A., Bassel-Duby, R., & Olson, E. N. (2008) · Journal of Clinical Investigation · doi:10.1172/jci33255 · Cited by 249
Kirchhefer, U. (1999) · Cardiovascular Research · doi:10.1016/s0008-6363(98)00296-x · Cited by 248
Purcell, N. H., Wilkins, B. J., York, A., Saba-El-Leil, M. K., Meloche, S., Robbins, J., & Molkentin, J. D. (2007) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0610906104 · Cited by 246
Gender Differences in Left Ventricular Growth
de Simone, G., Devereux, R. B., Daniels, S. R., & Meyer, R. A. (1995) · Hypertension · doi:10.1161/01.hyp.26.6.979 · Cited by 245
Zhang, T., Johnson, E. N., Gu, Y., Morissette, M. R., Sah, V. P., Gigena, M. S., Belke, D. D., Dillmann, W. H., Rogers, T. B., Schulman, H., et al. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m108525200 · Cited by 244
Gender differences in molecular remodeling in pressure overload hypertrophy
Weinberg, E. O., Thienelt, C. D., Katz, S. E., Bartunek, J., Tajima, M., Rohrbach, S., Douglas, P. S., & Lorell, B. H. (1999) · Journal of the American College of Cardiology · doi:10.1016/s0735-1097(99)00165-5 · Cited by 240
Mechanical stretch activates the stress‐activated protein kinase in cardiac myocytes
Komuro, I., Kudo, S., Yamazaki, T., Zou, Y., Shiojima, I., & Yazaki, Y. (1996) · The FASEB Journal · doi:10.1096/fasebj.10.5.8621062 · Cited by 239
Takeishi, Y., Ping, P., Bolli, R., Kirkpatrick, D. L., Hoit, B. D., & Walsh, R. A. (2000) · Circulation Research · doi:10.1161/01.res.86.12.1218 · Cited by 239
Control of cardiac myosin heavy chain gene expression
Morkin, E. (2000) · Microscopy Research and Technique · doi:10.1002/1097-0029(20000915)50:6<522::aid-jemt9>3.0.co;2-u · Cited by 238
Nishida, K., Yamaguchi, O., Hirotani, S., Hikoso, S., Higuchi, Y., Watanabe, T., Takeda, T., Osuka, S., Morita, T., Kondoh, G., et al. (2004) · Molecular and Cellular Biology · doi:10.1128/mcb.24.24.10611-10620.2004 · Cited by 238
AT2 receptors: Functional relevance in cardiovascular disease
Jones, E. S., Vinh, A., McCarthy, C. A., Gaspari, T. A., & Widdop, R. E. (2008) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2008.08.009 · Cited by 237
Impaired cardiac hypertrophic response in Calcineurin Aβ -deficient mice
Bueno, O. F., Wilkins, B. J., Tymitz, K. M., Glascock, B. J., Kimball, T. F., Lorenz, J. N., & Molkentin, J. D. (2002) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.072647999 · Cited by 237
IMPACT OF DIFFERENT SPORTS AND TRAINING ON CARDIAC STRUCTURE AND FUNCTION
Fagard, R. H. (1997) · Cardiology Clinics · doi:10.1016/s0733-8651(05)70348-9 · Cited by 236
Molecular and Functional Signature of Heart Hypertrophy During Pregnancy
Eghbali, M., Deva, R., Alioua, A., Minosyan, T. Y., Ruan, H., Wang, Y., Toro, L., & Stefani, E. (2005) · Circulation Research · doi:10.1161/01.res.0000170652.71414.16 · Cited by 233
Ramirez, M. T., Sah, V. P., Zhao, X.-L., Hunter, J. J., Chien, K. R., & Brown, J. H. (1997) · Journal of Biological Chemistry · doi:10.1074/jbc.272.22.14057 · Cited by 233
Glycogen Synthase Kinase 3β Regulates GATA4 in Cardiac Myocytes
Morisco, C., Seta, K., Hardt, S. E., Lee, Y., Vatner, S. F., & Sadoshima, J. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m103166200 · Cited by 232
Fatty acid metabolism is enhanced in type 2 diabetic hearts
Carley, A. N., & Severson, D. L. (2005) · Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids · doi:10.1016/j.bbalip.2005.03.005 · Cited by 232
Requirement of protein kinase D1 for pathological cardiac remodeling
Fielitz, J., Kim, M.-S., Shelton, J. M., Qi, X., Hill, J. A., Richardson, J. A., Bassel-Duby, R., & Olson, E. N. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0712265105 · Cited by 232
Senbonmatsu, T., Ichihara, S., Price, E., Gaffney, F. A., & Inagami, T. (2000) · Journal of Clinical Investigation · doi:10.1172/jci10037 · Cited by 230
Bowman, J. C., Steinberg, S. F., Jiang, T., Geenen, D. L., Fishman, G. I., & Buttrick, P. M. (1997) · Journal of Clinical Investigation · doi:10.1172/jci119755 · Cited by 229
Regulation of phosphoinositide 3-kinase expression in health and disease
Kok, K., Geering, B., & Vanhaesebroeck, B. (2009) · Trends in Biochemical Sciences · doi:10.1016/j.tibs.2009.01.003 · Cited by 228
Forfar, J. C., Muir, A. L., Sawers, S. A., & Toft, A. D. (1982) · New England Journal of Medicine · doi:10.1056/nejm198211043071901 · Cited by 228
Hwang, J.-J., Allen, P. D., Tseng, G. C., Lam, C.-W., Fananapazir, L., Dzau, V. J., & Liew, C.-C. (2002) · Physiological Genomics · doi:10.1152/physiolgenomics.00122.2001 · Cited by 228
Rohrer, D., & Dillmann, W. H. (1988) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)68584-9 · Cited by 227
Lüscher, T. F., Enseleit, F., Pacher, R., Mitrovic, V., Schulze, M. R., Willenbrock, R., Dietz, R., Rousson, V., Hürlimann, D., Philipp, S., et al. (2002) · Circulation · doi:10.1161/01.cir.0000038497.80095.e1 · Cited by 227
Aoki, H., Izumo, S., & Sadoshima, J. (1998) · Circulation Research · doi:10.1161/01.res.82.6.666 · Cited by 226
De Windt, L. J., Lim, H. W., Taigen, T., Wencker, D., Condorelli, G., Dorn, G. W., Kitsis, R. N., & Molkentin, J. D. (2000) · Circulation Research · doi:10.1161/01.res.86.3.255 · Cited by 225
Hayakawa, Y., Chandra, M., Miao, W., Shirani, J., Brown, J. H., Dorn, G. W., Armstrong, R. C., & Kitsis, R. N. (2003) · Circulation · doi:10.1161/01.cir.0000101920.72665.58 · Cited by 224
Kenessey, A., & Ojamaa, K. (2006) · Journal of Biological Chemistry · doi:10.1074/jbc.m512671200 · Cited by 222
Yang, J., Moravec, C. S., Sussman, M. A., DiPaola, N. R., Fu, D., Hawthorn, L., Mitchell, C. A., Young, J. B., Francis, G. S., McCarthy, P. M., et al. (2000) · Circulation · doi:10.1161/01.cir.102.25.3046 · Cited by 222
Estrogen receptor beta mediates gender differences in ischemia/reperfusion injury
GABEL, S., WALKER, V, LONDON, R., STEENBERGEN, C., KORACH, K., & MURPHY, E. (2005) · Journal of Molecular and Cellular Cardiology · doi:10.1016/j.yjmcc.2004.11.013 · Cited by 222
T. Duckett Jones Memorial Lecture. The Jones criteria and the challenges of clinimetrics.
Feinstein, A. R. (1982) · Circulation · doi:10.1161/01.cir.66.1.1 · Cited by 220
Keller, H. (1995) · Molecular Endocrinology · doi:10.1210/me.9.7.794 · Cited by 220
A new type of ERK1/2 autophosphorylation causes cardiac hypertrophy
Lorenz, K., Schmitt, J. P., Schmitteckert, E. M., & Lohse, M. J. (2009) · Nature Medicine · doi:10.1038/nm.1893 · Cited by 220
Cohn, J. N., Bristow, M. R., Chien, K. R., Colucci, W. S., Frazier, O. H., Leinwand, L. A., Lorell, B. H., Moss, A. J., Sonnenblick, E. H., Walsh, R. A., et al. (1997) · Circulation · doi:10.1161/01.cir.95.4.766 · Cited by 219
Proposed Update of Angiotensin Receptor Nomenclature
de Gasparo, M., Husain, A., Alexander, W., Catt, K. J., Chiu, A. T., Drew, M., Goodfriend, T., Harding, J. W., Inagami, T., & Timmermans, P. B. M. W. M. (1995) · Hypertension · doi:10.1161/01.hyp.25.5.924 · Cited by 219
Does load-induced ventricular hypertrophy progress to systolic heart failure?
Berenji, K., Drazner, M. H., Rothermel, B. A., & Hill, J. A. (2005) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.01303.2004 · Cited by 217
Modulation of Estrogen Receptor-α Transcriptional Activity by the Coactivator PGC-1
Tcherepanova, I., Puigserver, P., Norris, J. D., Spiegelman, B. M., & McDonnell, D. P. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.m001364200 · Cited by 217
Skavdahl, M., Steenbergen, C., Clark, J., Myers, P., Demianenko, T., Mao, L., Rockman, H. A., Korach, K. S., & Murphy, E. (2005) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.00723.2004 · Cited by 216
Neri Serneri, G. G., Boddi, M., Modesti, P. A., Cecioni, I., Coppo, M., Padeletti, L., Michelucci, A., Colella, A., & Galanti, G. (2001) · Circulation Research · doi:10.1161/hh2301.100982 · Cited by 216
Insulin-Like Growth Factor I Receptor Signaling Is Required for Exercise-Induced Cardiac Hypertrophy
Kim, J., Wende, A. R., Sena, S., Theobald, H. A., Soto, J., Sloan, C., Wayment, B. E., Litwin, S. E., Holzenberger, M., LeRoith, D., et al. (2008) · Molecular Endocrinology · doi:10.1210/me.2008-0265 · Cited by 215
Myocyte Adrenoceptor Signaling Pathways
Xiang, Y., & Kobilka, B. K. (2003) · Science · doi:10.1126/science.1079206 · Cited by 214
Cook, S. A., Sugden, P. H., & Clerk, A. (1999) · Journal of Molecular and Cellular Cardiology · doi:10.1006/jmcc.1999.0979 · Cited by 213
The role of the Grb2–p38 MAPK signaling pathway in cardiac hypertrophy and fibrosis
Zhang, S., Weinheimer, C., Courtois, M., Kovacs, A., Zhang, C. E., Cheng, A. M., Wang, Y., & Muslin, A. J. (2003) · Journal of Clinical Investigation · doi:10.1172/jci16290 · Cited by 213
Nuclear Targeting of Akt Enhances Kinase Activity and Survival of Cardiomyocytes
Shiraishi, I., Melendez, J., Ahn, Y., Skavdahl, M., Murphy, E., Welch, S., Schaefer, E., Walsh, K., Rosenzweig, A., Torella, D., et al. (2004) · Circulation Research · doi:10.1161/01.res.0000124394.01180.be · Cited by 212
Endothelin Receptor Blockers in Cardiovascular Disease
Rich, S., & McLaughlin, V. V. (2003) · Circulation · doi:10.1161/01.cir.0000094397.19932.78 · Cited by 212
Nuclear thyroid hormone receptors.
Lazar, M. A., & Chin, W. W. (1990) · Journal of Clinical Investigation · doi:10.1172/jci114906 · Cited by 210
Ramirez, M. T., Zhao, X.-L., Schulman, H., & Brown, J. H. (1997) · Journal of Biological Chemistry · doi:10.1074/jbc.272.49.31203 · Cited by 210
The GH–IGF‐I axis and the cardiovascular system: clinical implications
Colao, A. (2008) · Clinical Endocrinology · doi:10.1111/j.1365-2265.2008.03292.x · Cited by 209
Pw, C., COWELL, T. K., & Nl, D. (1964) · PubMed · Cited by 207
A role for Sp and nuclear receptor transcription factors in a cardiac hypertrophic growth program
Sack, M. N., Disch, D. L., Rockman, H. A., & Kelly, D. P. (1997) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.94.12.6438 · Cited by 206
Estrogen Receptor-Mediated Rapid Signaling
Moriarty, K., Kim, K. H., & Bender, J. R. (2006) · Endocrinology · doi:10.1210/en.2006-0729 · Cited by 205
O’Connell, T. D., Ishizaka, S., Nakamura, A., Swigart, P. M., Rodrigo, M. C., Simpson, G. L., Cotecchia, S., Rokosh, D. G., Grossman, W., Foster, E., et al. (2003) · Journal of Clinical Investigation · doi:10.1172/jci16100 · Cited by 205
Cardiac GPCRs: GPCR signaling in healthy and failing hearts
Salazar, N. C., Chen, J., & Rockman, H. A. (2007) · Biochimica et Biophysica Acta (BBA) - Biomembranes · doi:10.1016/j.bbamem.2007.02.010 · Cited by 205
Naga Prasad, S. V., Esposito, G., Mao, L., Koch, W. J., & Rockman, H. A. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.275.7.4693 · Cited by 204
Sex modifies exercise and cardiac adaptation in mice
Konhilas, J. P., Maass, A. H., Luckey, S. W., Stauffer, B. L., Olson, E. N., & Leinwand, L. A. (2004) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.00292.2004 · Cited by 203
Targeted inhibition of calcineurin attenuates cardiac hypertrophy in vivo
De Windt, L. J., Lim, H. W., Bueno, O. F., Liang, Q., Delling, U., Braz, J. C., Glascock, B. J., Kimball, T. F., del Monte, F., Hajjar, R. J., et al. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.031371998 · Cited by 202
Friddle, C. J., Koga, T., Rubin, E. M., & Bristow, J. (2000) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.100127897 · Cited by 201
Braz, J. C., Bueno, O. F., De Windt, L. J., & Molkentin, J. D. (2002) · The Journal of Cell Biology · doi:10.1083/jcb.200108062 · Cited by 199
Class IA Phosphoinositide 3-Kinase Regulates Heart Size and Physiological Cardiac Hypertrophy
Luo, J., McMullen, J. R., Sobkiw, C. L., Zhang, L., Dorfman, A. L., Sherwood, M. C., Logsdon, M. N., Horner, J. W., DePinho, R. A., Izumo, S., et al. (2005) · Molecular and Cellular Biology · doi:10.1128/mcb.25.21.9491-9502.2005 · Cited by 198
Self-citationSignaling chromatin to make muscle
McKinsey, T. A., Zhang, C. L., & Olson, E. N. (2002) · Current Opinion in Cell Biology · doi:10.1016/s0955-0674(02)00389-7 · Cited by 198
Liang, Q. (2003) · The EMBO Journal · doi:10.1093/emboj/cdg474 · Cited by 197
Serneri, G. G. N., Boddi, M., Cecioni, I., Vanni, S., Coppo, M., Papa, M. L., Bandinelli, B., Bertolozzi, I., Polidori, G., Toscano, T., et al. (2001) · Circulation Research · doi:10.1161/hh0901.089882 · Cited by 197
Role of the stress-activated protein kinases in endothelin-induced cardiomyocyte hypertrophy.
Choukroun, G., Hajjar, R., Kyriakis, J. M., Bonventre, J. V., Rosenzweig, A., & Force, T. (1998) · Journal of Clinical Investigation · doi:10.1172/jci3512 · Cited by 193
Exercise Can Prevent and Reverse the Severity of Hypertrophic Cardiomyopathy
Konhilas, J. P., Watson, P. A., Maass, A., Boucek, D. M., Horn, T., Stauffer, B. L., Luckey, S. W., Rosenberg, P., & Leinwand, L. A. (2006) · Circulation Research · doi:10.1161/01.res.0000205766.97556.00 · Cited by 192
Metabolic remodelling of the failing heart: beneficial or detrimental?
van Bilsen, M., van Nieuwenhoven, F. A., & van der Vusse, G. J. (2008) · Cardiovascular Research · doi:10.1093/cvr/cvn282 · Cited by 190
Hoshijima, M., Sah, V. P., Wang, Y., Chien, K. R., & Brown, J. H. (1998) · Journal of Biological Chemistry · doi:10.1074/jbc.273.13.7725 · Cited by 189
Aikawa, R., Komuro, I., Yamazaki, T., Zou, Y., Kudoh, S., Zhu, W., Kadowaki, T., & Yazaki, Y. (1999) · Circulation Research · doi:10.1161/01.res.84.4.458 · Cited by 188
Altered Glucose and Fatty Acid Oxidation in Hearts of the Spontaneously Hypertensive Rat
Christe, M. E., & Rodgers, R. L. (1994) · Journal of Molecular and Cellular Cardiology · doi:10.1006/jmcc.1994.1155 · Cited by 187
Pretorius, L., Du, X.-J., Woodcock, E. A., Kiriazis, H., Lin, R. C. Y., Marasco, S., Medcalf, R. L., Ming, Z., Head, G. A., Tan, J. W., et al. (2009) · The American Journal of Pathology · doi:10.2353/ajpath.2009.090126 · Cited by 187
Self-citationBisping, E., Ikeda, S., Kong, S. W., Tarnavski, O., Bodyak, N., McMullen, J. R., Rajagopal, S., Son, J. K., Ma, Q., Springer, Z., et al. (2006) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0602543103 · Cited by 185
Self-citationEdman, C. F., & Schulman, H. (1994) · Biochimica et Biophysica Acta (BBA) - Molecular Cell Research · doi:10.1016/0167-4889(94)90221-6 · Cited by 182
Cardiovascular endothelins: Essential regulators of cardiovascular homeostasis
Brunner, F., Brás-Silva, C., Cerdeira, A. S., & Leite-Moreira, A. F. (2006) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2005.11.001 · Cited by 182
Sarcomeric dysfunction in heart failure
Hamdani, N., Kooij, V., van Dijk, S., Merkus, D., Paulus, W. J., Remedios, C. D., Duncker, D. J., Stienen, G. J. M., & van der Velden, J. (2007) · Cardiovascular Research · doi:10.1093/cvr/cvm079 · Cited by 181
Koizumi, A., Nozaki, J.-I., Ohura, T., TsuyoshiKayo, Wada, Y., Nezu, J.-I., Ohashi, R., Tamai, I., Shoji, Y., Takada, G., et al. (1999) · Human Molecular Genetics · doi:10.1093/hmg/8.12.2247 · Cited by 179
Sarcomeric proteins and inherited cardiomyopathies
Morimoto, S. (2007) · Cardiovascular Research · doi:10.1093/cvr/cvm084 · Cited by 179
Naga Prasad, S. V., Barak, L. S., Rapacciuolo, A., Caron, M. G., & Rockman, H. A. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m102376200 · Cited by 179
Harris, I. S., Zhang, S., Treskov, I., Kovacs, A., Weinheimer, C., & Muslin, A. J. (2004) · Circulation · doi:10.1161/01.cir.0000138190.50127.6a · Cited by 177
Kagiyama, S., Eguchi, S., Frank, G. D., Inagami, T., Zhang, Y. C., & Phillips, M. I. (2002) · Circulation · doi:10.1161/01.cir.0000030181.63741.56 · Cited by 176
Kirkby, N. S., Hadoke, P. W. F., Bagnall, A. J., & Webb, D. J. (2008) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0707516 · Cited by 176
Growth of the heart in health and disease
Zak, R. (1984) · Raven Press eBooks · Cited by 175
Badorff, C., Ruetten, H., Mueller, S., Stahmer, M., Gehring, D., Jung, F., Ihling, C., Zeiher, A. M., & Dimmeler, S. (2002) · Journal of Clinical Investigation · doi:10.1172/jci13779 · Cited by 174
Choukroun, G., Hajjar, R., Fry, S., del Monte, F., Haq, S., Guerrero, J. L., Picard, M., Rosenzweig, A., & Force, T. (1999) · Journal of Clinical Investigation · doi:10.1172/jci6350 · Cited by 174
Myocardial Fibrosis in Transforming Growth Factor β1Heterozygous Mice
Brooks, W. W., & Conrad, C. H. (2000) · Journal of Molecular and Cellular Cardiology · doi:10.1006/jmcc.1999.1065 · Cited by 174
Heart physiology and pathophysiology
Sperelakis, N. (2001) · Cited by 172
DING, G., FU, M., QIN, Q., Lewis, W., Kim, H. W., Fukai, T., Bacanamwo, M., CHEN, Y., Schneider, M. D., Mangelsdorf, D. J., et al. (2007) · Cardiovascular Research · doi:10.1016/j.cardiores.2007.06.027 · Cited by 172
Thomas, W. G., Brandenburger, Y., Autelitano, D. J., Pham, T., Qian, H., & Hannan, R. D. (2002) · Circulation Research · doi:10.1161/hh0202.104109 · Cited by 172
Bikkina, M., Larson, M. G., & Levy, D. A. (1993) · Journal of the American College of Cardiology · doi:10.1016/0735-1097(93)90424-y · Cited by 172
Estrogenic hormone action in the heart: regulatory network and function
Babiker, F. (2002) · Cardiovascular Research · doi:10.1016/s0008-6363(01)00526-0 · Cited by 171
PDK1 regulates growth through Akt and S6K in Drosophila
Rintelen, F., Stocker, H., Thomas, G., & Hafen, E. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.011318098 · Cited by 170
Lin, R. C. Y., Weeks, K. L., Gao, X.-M., Williams, R. B. H., Bernardo, B. C., Kiriazis, H., Matthews, V. B., Woodcock, E. A., Bouwman, R. D., Mollica, J. P., et al. (2010) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/atvbaha.109.201988 · Cited by 170
Self-citationLouis, A., Cleland, J. G. F., Crabbe, S., Ford, S., Thackray, S., Houghton, T., & Clark, A. (2001) · European Journal of Heart Failure · doi:10.1016/s1388-9842(01)00149-0 · Cited by 169
Gelatinase B: Structure, Regulation, and Function
Vu, T. H., & Werb, Z. (1998) · Matrix Metalloproteinases · doi:10.1016/b978-012545090-4/50006-9 · Cited by 168
Gene Regulatory Mechanisms Governing Energy Metabolism during Cardiac Hypertrophic Growth
Lehman, J. J., & Kelly, D. P. (2002) · Heart Failure Reviews · doi:10.1023/a:1015332726303 · Cited by 167
Sadoshima, J., Montagne, O., Wang, Q., Yang, G., Warden, J., Liu, J., Takagi, G., Karoor, V., Hong, C., Johnson, G. L., et al. (2002) · Journal of Clinical Investigation · doi:10.1172/jci14938 · Cited by 167
β-Adrenergic Pathway Induces Apoptosis through Calcineurin Activation in Cardiac Myocytes
Saito, S., Hiroi, Y., Zou, Y., Aikawa, R., Toko, H., Shibasaki, F., Yazaki, Y., Nagai, R., & Komuro, I. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.m002844200 · Cited by 166
Context-specific inhibition of JNKs: overcoming the dilemma of protection and damage
WAETZIG, V, & HERDEGEN, T. (2005) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2005.07.006 · Cited by 166
Peng, X. (2005) · Journal of Clinical Investigation · doi:10.1172/jci24497 · Cited by 166
Regulation of Cardiac Stress Signaling by Protein Kinase D1
Harrison, B. C., Kim, M.-S., van Rooij, E., Plato, C. F., Papst, P. J., Vega, R. B., McAnally, J., Richardson, J. A., Bassel‐Duby, R., Olson, E. N., et al. (2006) · Molecular and Cellular Biology · doi:10.1128/mcb.26.10.3875-3888.2006 · Cited by 165
Apoptosis of Cardiac Myocytes in Gsα Transgenic Mice
Geng, Y.-J., Ishikawa, Y., Vatner, D. E., Wagner, T. E., Bishop, S. P., Vatner, S. F., & Homcy, C. J. (1999) · Circulation Research · doi:10.1161/01.res.84.1.34 · Cited by 165
Akt2 Regulates Cardiac Metabolism and Cardiomyocyte Survival
DeBosch, B., Sambandam, N., Weinheimer, C., Courtois, M., & Muslin, A. J. (2006) · Journal of Biological Chemistry · doi:10.1074/jbc.m513087200 · Cited by 164
Renin-Angiotensin System, Hypertrophy and Gene Expression in Cardiac Myocytes
Lijnen, P., & Petrov, V. (1999) · Journal of Molecular and Cellular Cardiology · doi:10.1006/jmcc.1999.0934 · Cited by 164
Cardiocyte Adaptation to Chronically Altered Load
Cooper, G. (1987) · Annual Review of Physiology · doi:10.1146/annurev.ph.49.030187.002441 · Cited by 163
Delaughter, M. C., Taffet, G. E., Fiorotto, M. L., Entman, M. L., & Schwartz, R. J. (1999) · The FASEB Journal · doi:10.1096/fasebj.13.14.1923 · Cited by 162
Myostatin Regulates Cardiomyocyte Growth Through Modulation of Akt Signaling
Morissette, M. R., Cook, S. A., Foo, S., McKoy, G., Ashida, N., Novikov, M., Scherrer‐Crosbie, M., Li, L., Matsui, T., Brooks, G., et al. (2006) · Circulation Research · doi:10.1161/01.res.0000231290.45676.d4 · Cited by 162
Survival pathways in hypertrophy and heart failure: The gp130-STAT3 axis
Fischer, P., & Hilfiker-Kleiner, D. (2007) · Basic Research in Cardiology · doi:10.1007/s00395-007-0658-z · Cited by 162
Small Guanine Nucleotide-Binding Proteins and Myocardial Hypertrophy
Clerk, A., & Sugden, P. H. (2000) · Circulation Research · doi:10.1161/01.res.86.10.1019 · Cited by 161
Huynh, K., McMullen, J. R., Julius, T. L., Tan, J. W., Love, J. E., Cemerlang, N., Kiriazis, H., Du, X., & Ritchie, R. H. (2010) · Diabetes · doi:10.2337/db09-1456 · Cited by 161
Self-citationKodama, H., Fukuda, K., Pan, J., Makino, S., Baba, A., Hori, S., & Ogawa, S. (1997) · Circulation Research · doi:10.1161/01.res.81.5.656 · Cited by 160
A cardiac myosin light chain kinase regulates sarcomere assembly in the vertebrate heart
Seguchi, O., Takashima, S., Yamazaki, S., Asakura, M., Asano, Y., Shintani, Y., Wakeno, M., Minamino, T., Kondo, H., Furukawa, H., et al. (2007) · Journal of Clinical Investigation · doi:10.1172/jci30804 · Cited by 159
Ikeda, Y., Aihara, K., Sato, T., Akaike, M., Yoshizumi, M., Suzaki, Y., Izawa, Y., Fujimura, M., Hashizume, S., Kato, M., et al. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m411694200 · Cited by 159
Phosphoinositide 3-Kinase γ–Deficient Mice Are Protected From Isoproterenol-Induced Heart Failure
Oudit, G. Y., Crackower, M. A., Eriksson, U., Sarao, R., Kozieradzki, I., Sasaki, T., Irie-Sasaki, J., Gidrewicz, D., Rybin, V. O., Wada, T., et al. (2003) · Circulation · doi:10.1161/01.cir.0000091403.62293.2b · Cited by 159
Krum, H., & Abraham, W. T. (2009) · The Lancet · doi:10.1016/s0140-6736(09)60236-1 · Cited by 159
Calcineurin Expression, Activation, and Function in Cardiac Pressure-Overload Hypertrophy
Lim, H. W., De Windt, L. J., Steinberg, L., Taigen, T., Witt, S. A., Kimball, T. R., & Molkentin, J. D. (2000) · Circulation · doi:10.1161/01.cir.101.20.2431 · Cited by 158
MicroRNAs and Their Role in Progressive Kidney Diseases
Kato, M., Arce, L., & Natarajan, R. (2009) · Clinical Journal of the American Society of Nephrology · doi:10.2215/cjn.00520109 · Cited by 158
Serum levels of total and free IGF-I and IGFBP-3 are increased and maintained in long-term training
Koziris, L. P., Hickson, R. C., Chatterton, R. T., Groseth, R. T., Christie, J. M., Goldflies, D. G., & Unterman, T. G. (1999) · Journal of Applied Physiology · doi:10.1152/jappl.1999.86.4.1436 · Cited by 157
Physiological and pathological cardiac hypertrophy induce different molecular phenotypes in the rat
Iemitsu, M., Miyauchi, T., Maeda, S., Sakai, S., Kobayashi, T., FUJII, N. L., Miyazaki, H., Matsuda, M., & Yamaguchi, I. (2001) · American Journal of Physiology-Regulatory, Integrative and Comparative Physiology · doi:10.1152/ajpregu.2001.281.6.r2029 · Cited by 157
Estrogen receptor alpha up‐regulation and redistribution in human heart failure
Mahmoodzadeh, S., Eder, S., Nordmeyer, J., Ehler, E., Huber, O., Martus, P., Weiske, J., Pregla, R., Hetzer, R., & Regitz‐Zagrosek, V. (2006) · The FASEB Journal · doi:10.1096/fj.05-5148com · Cited by 155
Gupta, M. P., Samant, S. A., Smith, S. H., & Shroff, S. G. (2008) · Journal of Biological Chemistry · doi:10.1074/jbc.m710277200 · Cited by 154
1-Adrenergic receptors prevent a maladaptive cardiac response to pressure overload
O’Connell, T. D., Swigart, P. M., Rodrigo, M. C., Ishizaka, S., Joho, S., Turnbull, L., Tecott, L. H., Baker, A. J., Foster, E., Grossman, W., et al. (2006) · Journal of Clinical Investigation · doi:10.1172/jci22811 · Cited by 152
Scheuer, J., Malhotra, A., Hirsch, C., Capasso, J. M., & Schaible, T. (1982) · Journal of Clinical Investigation · doi:10.1172/jci110729 · Cited by 151
Regulation of Mitogen-Activated Protein Kinases in Cardiac Myocytes through the Small G Protein Rac1
Clerk, A., Pham, F. H., Fuller, S. J., Sahai, E. A., Aktories, K., Marais, R., Marshall, C., & Sugden, P. H. (2001) · Molecular and Cellular Biology · doi:10.1128/mcb.21.4.1173-1184.2001 · Cited by 150
Calcineurin Plays a Critical Role in Pressure Overload–Induced Cardiac Hypertrophy
Shimoyama, M., Hayashi, D., Takimoto, E., Zou, Y., Oka, T., Uozumi, H., Kudoh, S., Shibasaki, F., Yazaki, Y., Nagai, R., et al. (1999) · Circulation · doi:10.1161/01.cir.100.24.2449 · Cited by 149
Signalling pathways in cardiac myocyte hypertrophy.
Sugden, P. H. (2001) · PubMed · Cited by 148
Pracyk, J. B., Tanaka, K., Hegland, D. D., Kim, K. S., Sethi, R., Rovira, I. I., Blazina, D. R., Lee, L., Bruder, J. T., Kovesdi, I., et al. (1998) · Journal of Clinical Investigation · doi:10.1172/jci2552 · Cited by 148
Donaldson, C., Eder, S., Baker, C., Aronovitz, M. J., Weiss, A. D., Hall-Porter, M. R., Wang, F., Ackerman, A. M., Karas, R. H., Molkentin, J. D., et al. (2008) · Circulation Research · doi:10.1161/circresaha.108.190397 · Cited by 147
Bossuyt, J., Helmstadter, K. G., Wu, X., Clements‐Jewery, H., Haworth, R. S., Avkiran, M., Martin, J. W., Pogwizd, S. M., & Bers, D. M. (2008) · Circulation Research · doi:10.1161/circresaha.107.169755 · Cited by 146
Welch, S., Plank, D. M., Witt, S. A., Glascock, B. J., Schaefer, E., Chimenti, S., Andreoli, A. M., Limana, F., Leri, A., Kajstura, J., et al. (2002) · Circulation Research · doi:10.1161/01.res.0000013780.77774.75 · Cited by 144
Luczak, E. D., & Leinwand, L. A. (2009) · Annual Review of Physiology · doi:10.1146/annurev.physiol.010908.163156 · Cited by 143
CD36 Expression Contributes to Age-Induced Cardiomyopathy in Mice
Koonen, D. P. Y., Febbraio, M., Bonnet, S., Nagendran, J., Young, M. E., Michelakis, E. D., & Dyck, J. R. B. (2007) · Circulation · doi:10.1161/circulationaha.107.712901 · Cited by 142
Nienaber, J. J., Tachibana, H., Prasad, S. V. N., Esposito, G., Wu, D., Mao, L., & Rockman, H. A. (2003) · Journal of Clinical Investigation · doi:10.1172/jci18213 · Cited by 142
Kaumann, A. J., Bartel, S., Molenaar, P., Sanders, L., Burrell, K. M., Vetter, D., Hempel, P., Karczewski, P., & Krause, E. (1999) · Circulation · doi:10.1161/01.cir.99.1.65 · Cited by 141
Wang, L., & Proud, C. G. (2002) · Circulation Research · doi:10.1161/01.res.0000041029.97988.e9 · Cited by 141
Rupp, H. (1981) · Basic Research in Cardiology · doi:10.1007/bf01908164 · Cited by 139
Douglas, P. S., Otto, C. M., Mickel, M. C., Labovitz, A. J., Reid, C. L., & Davis, K. B. (1995) · Heart · doi:10.1136/hrt.73.6.548 · Cited by 139
Cited by
Mechanisms of physiological and pathological cardiac hypertrophy
Nakamura, M., & Sadoshima, J. (2018) · Nature Reviews Cardiology · doi:10.1038/s41569-018-0007-y · Cited by 1,658
Physiological and pathological cardiac hypertrophy
Shimizu, I., & Minamino, T. (2016) · Journal of Molecular and Cellular Cardiology · doi:10.1016/j.yjmcc.2016.06.001 · Cited by 887
Loss of Cardiac Ferritin H Facilitates Cardiomyopathy via Slc7a11-Mediated Ferroptosis
Fang, X., Cai, Z., Wang, H., Han, D., Cheng, Q., Zhang, P., Gao, F., Yu, Y., Song, Z., Wu, Q., et al. (2020) · Circulation Research · doi:10.1161/circresaha.120.316509 · Cited by 770
Tham, Y. K., Bernardo, B. C., Ooi, J. Y. Y., Weeks, K. L., & McMullen, J. R. (2015) · Archives of Toxicology · doi:10.1007/s00204-015-1477-x · Cited by 708
Self-citationHuynh, K., Bernardo, B. C., McMullen, J. R., & Ritchie, R. H. (2014) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2014.01.003 · Cited by 553
Self-citation
Metadata
- Authors
- Bernardo, B. C., Weeks, K. L., Pretorius, L., & McMullen, J. R.
- Venue
- Pharmacology & Therapeutics
- Publisher
- Elsevier BV
- Published
- 2010-10
- Volume
- 128
- Issue
- 1
- Pages
- 191-227
- ISSN
- 0163-7258 (ISSN-L)
- OpenAlex
- W2021458745
- Cited by
- 894
- References
- 575
- FWCI
- 25.96
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.